News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Transpharma-Medical To Announce Promising Results Of Clinical Trials With Its hPTH (1-34) -Transdermal Delivery Product For Osteoporosis Treatment


3/29/2006 12:46:57 PM

TransPharma-Medical Ltd., the Israeli-based specialty pharma company that develops pharmaceutical products based on its unique RF-MicroChannels™ transdermal drug delivery technology, announces promising results of first human clinical trials demonstrating transdermal delivery of human Parathyroid Hormone 1-34 fragment, (hPTH 1-34)for the treatment of osteoporosis.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES